TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22435741

Group type: EXPERIMENTAL
Intervention: Oral sumatriptan (various dose sizes) without MAOI‐A
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral sumatriptan (various dose sizes) with MAOI‐A
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral almotriptan
Number of subjects: 0

Group type: COMPARATOR
Intervention: MAOI‐A
Number of subjects: 0
Study: 20804366

Group type: EXPERIMENTAL
Intervention: Tongue acupuncture (40 sessions over 8 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham tongue acupuncture to nonacupoints in the tongue
Number of subjects: 50
Study: 18184934

Group type: EXPERIMENTAL
Intervention: Simplified version of a habit reversal treatment (awareness training, self-monitoring, competing responses, and social support)
Number of subjects: 1
Study: 16415708

Group type: EXPERIMENTAL
Intervention: Topiramate (25 to 200 mg/d)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 14636088

Group type: EXPERIMENTAL
Intervention: 4-week plyometric training program
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 7-week plyometric training program
Number of subjects: 38
Study: 10577699

Group type: EXPERIMENTAL
Intervention: Continuous, hyperfractionated, accelerated radiotherapy (CHART) - 36 fractions of 1.5 Gy 3 times per day to give 54 Gy in 12 consecutive days
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: Continuous, hyperfractionated, accelerated radiotherapy (CHART)
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: Continuous, hyperfractionated, accelerated radiotherapy (CHART) in squamous cell cancer
Number of subjects: 563
Study: 8918509

Group type: EXPERIMENTAL
Intervention: Supportive group sessions and free nicotine supplementation (patches, chewing gum)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 400
Study: 1801964

Group type: EXPERIMENTAL
Intervention: Danazol (200 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Danazol (400 mg)
Number of subjects: 16
Study: 6863583

Group type: EXPERIMENTAL
Intervention: experimenter-administered time-out of fixed duration
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: experimenter-administered time-out of duration determined by the subject
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: self-initiated time-out of fixed duration
Number of subjects: 33
Study: 31125092

Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg SC Q6M (long-term)
Number of subjects: 4074

Group type: COMPARATOR
Intervention: Placebo (crossover)
Number of subjects: 4074
Study: 27862923

Group type: EXPERIMENTAL
Intervention: 50% reduction in TacER dose with targeted TacER trough level (C0) >3 μg/L (Group A)
Number of subjects: 186

Group type: COMPARATOR
Intervention: No change in TacER dose (TacER C0 7-12 μg/L) (Group B)
Number of subjects: 186
Study: 25760561

Group type: EXPERIMENTAL
Intervention: Low-dose spiral computed tomography (LDCT) screening
Number of subjects: 1264

Group type: COMPARATOR
Intervention: Control (yearly clinical review only)
Number of subjects: 1264
Study: 24322192

Group type: EXPERIMENTAL
Intervention: Specific acupuncture (Group I)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-specific acupuncture (Group II)
Number of subjects: 0
Study: 21299874

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate infusion
Number of subjects: 875
Study: 18834718

Group type: EXPERIMENTAL
Intervention: Fatigue-inducing mental session
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Fatigue-inducing physical session
Number of subjects: 54
Study: 17267907

Group type: EXPERIMENTAL
Intervention: Proactive end‐of‐life conference and brochure
Number of subjects: 126

Group type: COMPARATOR
Intervention: Customary end‐of‐life conference
Number of subjects: 126
Study: 15063379

Group type: EXPERIMENTAL
Intervention: Video of the instructor giving the lecture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Audio slide presentation
Number of subjects: 0
Study: 11961371

Group type: EXPERIMENTAL
Intervention: Influenza vaccination
Number of subjects: 729
Study: 9818860

Group type: EXPERIMENTAL
Intervention: Open craniotomy within 12 hours of ICH symptom onset
Number of subjects: 34

Group type: COMPARATOR
Intervention: Best medical therapy
Number of subjects: 34
Study: 8748041

Group type: EXPERIMENTAL
Intervention: Risperidone (4-8 mg/day)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Active controls (haloperidol, perphenazine, zuclopenthixol)
Number of subjects: 6
Study: 2497135

Group type: EXPERIMENTAL
Intervention: GnRH-a treatment starting 4-7 days after ovulation (Group 1)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: GnRH-a treatment starting 8-10 days after ovulation (Group 2)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: GnRH-a treatment starting 1-3 days after the onset of menses (Group 3)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 44
Study: 142005

Group type: EXPERIMENTAL
Intervention: Oral 8-MOP-UVA treatment (12 patients)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Topical treatment (7 patients)
Number of subjects: 19
Study: 6983966

Group type: EXPERIMENTAL
Intervention: Carprofen 150 mg daily, b.i.d. administration
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Carprofen 300 mg daily, b.i.d. administration
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Carprofen 300 mg daily, t.i.d. administration
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Carprofen 300 mg daily
Number of subjects: 80
Study: 31438346

Group type: EXPERIMENTAL
Intervention: Vibrotactile biofeedback from the posture trainer device
Number of subjects: 0

Group type: COMPARATOR
Intervention: No feedback
Number of subjects: 0
Study: 29242893

Group type: EXPERIMENTAL
Intervention: Supplemental Tier 2 vocabulary intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: First unit benchmark of the intervention
Number of subjects: 0
Study: 26771265

Group type: EXPERIMENTAL
Intervention: Low-normal anesthesia (BIS 40-45)
Number of subjects: 40

Group type: COMPARATOR
Intervention: High-normal anesthesia (BIS 55-60)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 25073833

Group type: EXPERIMENTAL
Intervention: Active pharmacotherapy
Number of subjects: 1065

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1065

Group type: EXPERIMENTAL
Intervention: High genetic risk with partner smoking
Number of subjects: 1065

Group type: EXPERIMENTAL
Intervention: High genetic risk without partner smoking
Number of subjects: 1065
Study: 21726301

Group type: EXPERIMENTAL
Intervention: Manual edge detection
Number of subjects: 984

Group type: EXPERIMENTAL
Intervention: Semi-automated edge detection
Number of subjects: 984

Group type: EXPERIMENTAL
Intervention: Lipid-lowering therapy (manual reading)
Number of subjects: 984

Group type: EXPERIMENTAL
Intervention: Lipid-lowering therapy (semi-automated reading)
Number of subjects: 984

Group type: COMPARATOR
Intervention: Placebo (manual reading)
Number of subjects: 984

Group type: COMPARATOR
Intervention: Placebo (semi-automated reading)
Number of subjects: 984
Study: 19841043

Group type: EXPERIMENTAL
Intervention: Vitamin D supplements
Number of subjects: 1604

Group type: EXPERIMENTAL
Intervention: Summer sunshine
Number of subjects: 1604

Group type: COMPARATOR
Intervention: No vitamin D supplements
Number of subjects: 1604
Study: 18065577

Group type: EXPERIMENTAL
Intervention: CHO diet (carbohydrate diet)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: MUFA diet (monounsaturated fatty acids diet)
Number of subjects: 85

Group type: COMPARATOR
Intervention: AAD (average American diet)
Number of subjects: 85
Study: 14740153

Group type: EXPERIMENTAL
Intervention: D‐hormones (alphacalcidol and calcitriol)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Calcitriol
Number of subjects: 17
Study: 10936784

Group type: EXPERIMENTAL
Intervention: Alkaline phosphatase (ALP) activity in patients with CHM
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Localization of enzyme activities in cryosections
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Thermostability of ALP
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Chemical inhibition study of ALP
Number of subjects: 12
Study: 9410139

Group type: EXPERIMENTAL
Intervention: Folstein's Mini Mental Test (MMT)
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Lobo's Cognitive Mini Exam (CME)
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Isaacs Set test
Number of subjects: 329
Study: 8104448

Group type: EXPERIMENTAL
Intervention: Atracurium and Vecuronium (10:1, 4:1, 1.6:1 dose ratios)
Number of subjects: 30
Study: 3594460

Group type: EXPERIMENTAL
Intervention: 1 g oxiracetam
Number of subjects: 12

Group type: COMPARATOR
Intervention: saline
Number of subjects: 12
Study: 28262474

Group type: EXPERIMENTAL
Intervention: eContour (interactive web-based contouring atlas)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Existing contouring resources
Number of subjects: 24
Study: 24730669

Group type: EXPERIMENTAL
Intervention: Tamsulosin
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Alfuzosin
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 48
Study: 23819964

Group type: EXPERIMENTAL
Intervention: Specialist medical and mental health unit
Number of subjects: 600

Group type: COMPARATOR
Intervention: Standard care (acute geriatric or general medical wards)
Number of subjects: 600
Study: 22816729

Group type: EXPERIMENTAL
Intervention: Linagliptin 2.5 mg twice daily
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Linagliptin 5 mg once daily
Number of subjects: 491

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 491
Study: 19710003

Group type: EXPERIMENTAL
Intervention: Ultra-low-dose end-expiratory CT
Number of subjects: 20
Study: 17460786

Group type: EXPERIMENTAL
Intervention: Paliperidone extended-release (ER) 3-15 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paliperidone extended-release (ER)
Number of subjects: 0
Study: 15639696

Group type: EXPERIMENTAL
Intervention: DMPA 104 mg/0.65 mL SC injection
Number of subjects: 24
Study: 11802821

Group type: EXPERIMENTAL
Intervention: Cognitive intervention programme (15 months)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual classroom programme
Number of subjects: 30
Study: 9593010

Group type: EXPERIMENTAL
Intervention: Rimantadine (100 mg orally, twice a day)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Rimantadine
Number of subjects: 105
Study: 7507135

Group type: EXPERIMENTAL
Intervention: Capsaicin cream 0.025%, 0.5% or 1.0% applied three times daily for 4 weeks
Number of subjects: 5

Group type: COMPARATOR
Intervention: Vehicle alone (control)
Number of subjects: 5
Study: 3219318

Group type: EXPERIMENTAL
Intervention: Ispaghula (14-15 g/d)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Guar gum
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Xanthan gum
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Viscous polysaccharides (general)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Gum feeding
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Hydrogen production from in vitro cultures
Number of subjects: 7
Study: 30963544

Group type: EXPERIMENTAL
Intervention: Extended Early Intervention Service (EEIS)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Regular Care (RC)
Number of subjects: 217
Study: 27182992

Group type: EXPERIMENTAL
Intervention: Intravenous Acetaminophen
Number of subjects: 40

Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 26389600

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (n = 59)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Resistance exercise (n = 63)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Combined exercise training (n = 60)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Sedentary control (n = 61)
Number of subjects: 243
Study: 23216584

Group type: EXPERIMENTAL
Intervention: Olmesartan/Amlodipine combination (20 mg/5 mg)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Olmesartan (20 mg)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Amlodipine (10 mg)
Number of subjects: 276
Study: 21392672

Group type: EXPERIMENTAL
Intervention: Light buccally directed orthodontic force of 25 g
Number of subjects: 36

Group type: COMPARATOR
Intervention: Heavy orthodontic force of 225 g
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Duration of force application (4, 8, or 12 weeks)
Number of subjects: 36
Study: 19216814

Group type: EXPERIMENTAL
Intervention: WHEY+CAS (casein and whey proteins mixture, 22 g protein, 836 kJ)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: CAS (casein only, 22 g protein, 836 kJ)
Number of subjects: 27
Study: 17943480

Group type: EXPERIMENTAL
Intervention: ERP+CT (Exposure with Response Prevention + Cognitive Therapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: ERP+REL (Exposure with Response Prevention + Relaxation Training)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ERP+REL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ERP+CT
Number of subjects: 0
Study: 15507959

Group type: EXPERIMENTAL
Intervention: Cerclage
Number of subjects: 61

Group type: COMPARATOR
Intervention: Bed rest
Number of subjects: 61
Study: 11902300

Group type: EXPERIMENTAL
Intervention: Intravenous ondansetron at 0.15 mg/kg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Intravenous ondansetron at 0.45 mg/kg
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 26
Study: 11579700

Group type: EXPERIMENTAL
Intervention: Lifting with a drawsheet
Number of subjects: 42

Group type: COMPARATOR
Intervention: Lifting without a drawsheet
Number of subjects: 42
Study: 8082533

Group type: COMPARATOR
Intervention: Liquid supplement only (Group A)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Supplement plus an evening meal (Group B)
Number of subjects: 40
Study: 2563239

Group type: EXPERIMENTAL
Intervention: Drug
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31574964

Group type: EXPERIMENTAL
Intervention: Local body vibration (LBV)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Non-LBV
Number of subjects: 24
Study: 28528899

Group type: EXPERIMENTAL
Intervention: American Congress of Obstetricians and Gynecologists summary
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: American College of Physicians summary
Number of subjects: 452

Group type: COMPARATOR
Intervention: First-phase participants (referent group)
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Overall belief about discussing benefits and harms
Number of subjects: 452
Study: 24595862

Group type: EXPERIMENTAL
Intervention: Plasma choline in nonsmokers (highest vs. lowest quartiles)
Number of subjects: 2568

Group type: COMPARATOR
Intervention: Plasma choline in smokers
Number of subjects: 2568

Group type: EXPERIMENTAL
Intervention: Plasma choline
Number of subjects: 2568

Group type: COMPARATOR
Intervention: Plasma betaine
Number of subjects: 2568
Study: 24173265

Group type: EXPERIMENTAL
Intervention: ePTFE membrane removal at 2 weeks (TGr)
Number of subjects: 12

Group type: COMPARATOR
Intervention: ePTFE membrane removal at 4 weeks (CGr)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both groups (TGr and CGr)
Number of subjects: 12
Study: 21871931

Group type: EXPERIMENTAL
Intervention: High heart rate reactivity
Number of subjects: 1647
Study: 20496613

Group type: EXPERIMENTAL
Intervention: Multiple micronutrients supplementation during pregnancy
Number of subjects: 31290

Group type: COMPARATOR
Intervention: Iron-folic acid supplementation during pregnancy
Number of subjects: 31290

Group type: EXPERIMENTAL
Intervention: Use of skilled birth attendant (SBA)
Number of subjects: 31290

Group type: EXPERIMENTAL
Intervention: Better-performing community facilitators
Number of subjects: 31290

Group type: EXPERIMENTAL
Intervention: Poorly performing community facilitators
Number of subjects: 31290
Study: 16752024

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg bid after a 400 mg loading dose
Number of subjects: 370

Group type: COMPARATOR
Intervention: Diclofenac SR 75 mg bid
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 370

Group type: COMPARATOR
Intervention: Diclofenac SR
Number of subjects: 370
Study: 15294086

Group type: EXPERIMENTAL
Intervention: Home-based nursing intervention
Number of subjects: 37

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 37
Study: 11473884

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25%
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (Sterile water)
Number of subjects: 36
Study: 9758713

Group type: EXPERIMENTAL
Intervention: Cysteamine 0.5% with 0.01% benzalkonium chloride
Number of subjects: 14

Group type: COMPARATOR
Intervention: Cystamine 0.5% with 0.01% benzalkonium chloride
Number of subjects: 14
Study: 1654410

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) at doses of 800-1,200 mg daily for a median of 52 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV)
Number of subjects: 0
Study: 6411944

Group type: EXPERIMENTAL
Intervention: Computer-generated letter reminders
Number of subjects: 590

Group type: EXPERIMENTAL
Intervention: Telephoned reminders
Number of subjects: 590

Group type: COMPARATOR
Intervention: No reminder (control group)
Number of subjects: 590

Group type: EXPERIMENTAL
Intervention: Telephoned or manual letter reminders
Number of subjects: 590
Study: 31894446

Group type: EXPERIMENTAL
Intervention: Rapid genetic counseling and testing
Number of subjects: 285

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 285
Study: 30700317

Group type: EXPERIMENTAL
Intervention: Moderately hypofractionated (HYPO) radiotherapy
Number of subjects: 140

Group type: COMPARATOR
Intervention: Conventionally fractionated (CF) radiotherapy
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Both HYPO and CF arms
Number of subjects: 140
Study: 29021235

Group type: EXPERIMENTAL
Intervention: morphine + ibuprofen
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: morphine
Number of subjects: 456

Group type: COMPARATOR
Intervention: ibuprofen
Number of subjects: 456
Study: 26766737

Group type: EXPERIMENTAL
Intervention: 12-week lifestyle intervention (supervised exercise training and dietary advice)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 50
Study: 23291349

Group type: EXPERIMENTAL
Intervention: Low-dose azithromycin
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Low-dose azithromycin (in non-eosinophilic severe asthma)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo (in non-eosinophilic severe asthma)
Number of subjects: 109
Study: 22314630

Group type: EXPERIMENTAL
Intervention: Music intervention (20 minutes of standard postoperative care and music twice daily on postoperative days 2 through 4)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (20 minutes of standard care with a quiet resting period twice daily on postoperative days 2 through 4)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 19647524

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Combination Treatment
Number of subjects: 69

Group type: COMPARATOR
Intervention: Light Therapy
Number of subjects: 69
Study: 17114878

Group type: EXPERIMENTAL
Intervention: Invasive treatment
Number of subjects: 1008

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 1008
Study: 15701209

Group type: EXPERIMENTAL
Intervention: Losartan (100 mg daily) in RENAAL study
Number of subjects: 1513

Group type: EXPERIMENTAL
Intervention: Losartan (100 mg daily) in LIFE study
Number of subjects: 1513

Group type: COMPARATOR
Intervention: Placebo in RENAAL study
Number of subjects: 1513

Group type: COMPARATOR
Intervention: Atenolol in LIFE study
Number of subjects: 1513
Study: 11699827

Group type: EXPERIMENTAL
Intervention: Controlled-release tablets of diclofenac sodium with HPMC and NaCMC (1:2:1 ratio)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Voveran SR
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dicloran SR
Number of subjects: 0
Study: 9872487

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol patches (50 microg daily) with intrauterine system releasing 20 microg of levonorgestrel daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oral dose of 2 mg of estradiol and 1 mg of norethisterone acetate daily
Number of subjects: 40
Study: 7520396

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment alone
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Frequent ejaculation alone
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment with frequent ejaculation
Number of subjects: 102

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 102
Study: 3123302

Group type: EXPERIMENTAL
Intervention: Elemental diet therapy (administered nocturnally, at home, by continuous nasogastric infusion)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Conventional medical therapy (control group)
Number of subjects: 8
Study: 30070045

Group type: EXPERIMENTAL
Intervention: Daily self-weighing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weekly weighing
Number of subjects: 0

Group type: COMPARATOR
Intervention: No weighing (excluded from analysis)
Number of subjects: 0
Study: 28032918

Group type: EXPERIMENTAL
Intervention: Illness Management and Recovery Program (IMR) for 12 months
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard care management by community psychiatric nurses for 12 months
Number of subjects: 50
Study: 25994742

Group type: EXPERIMENTAL
Intervention: Manual thrombectomy (using the Export catheter, Medtronic Cardiovascular)
Number of subjects: 214

Group type: COMPARATOR
Intervention: PCI-alone
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Manual thrombectomy
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Manual thrombectomy and PCI-alone
Number of subjects: 214
Study: 23940461

Group type: COMPARATOR
Intervention: Viral load (VL) monitoring
Number of subjects: 716

Group type: EXPERIMENTAL
Intervention: CD4 monitoring
Number of subjects: 716

Group type: EXPERIMENTAL
Intervention: Both monitoring strategies
Number of subjects: 716
Study: 22024492

Group type: COMPARATOR
Intervention: General low fat (LF) control
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Structured LF high polyunsaturated fat (PUFA) (LF-PUFA)
Number of subjects: 122